Tumor antigens for cancer immunotherapy: therapeutic potential of xenogeneic DNA vaccines

Por Srinivasan, Roopa, Wolchok, Jedd D
Publicado em 2004

Combining Cancer Immunotherapy and Targeted Therapy

Por Ribas, Antoni, Wolchok, Jedd D.
Publicado em 2013

Immunotherapy and the belly of the beast

Por Merghoub, Taha, Wolchok, Jedd D.
Publicado no J Exp Med (2014)

Potentiation of immunomodulatory antibody therapy with oncolytic viruses for treatment of cancer

Por Zamarin, Dmitriy, Wolchok, Jedd D
Publicado no Mol Ther Oncolytics (2014)

Successful Treatment of a Patient with Glioblastoma and a Germline POLE Mutation: Where Next?

Por Snyder, Alexandra, Wolchok, Jedd D.
Publicado no Cancer Discov (2016)

General principles of tumor immunotherapy Basic and Clinical Applications of Tumor Immunology /

Por Kaufman, Howard L., Wolchok, Jedd D.
Publicado em 2007

The heterogeneity of the kinetics of response to ipilimumab in metastatic melanoma: patient cases

Por Saenger, Yvonne M., Wolchok, Jedd D.
Publicado em 2008

At the Bedside: CTLA-4- and PD-1-blocking antibodies in cancer immunotherapy

Por Callahan, Margaret K., Wolchok, Jedd D.
Publicado em 2013

Immune Regulatory Antibodies: Are They the Next Advance?

Por Wolchok, Jedd D., Yang, Arvin S., Weber, Jeffrey S.
Publicado em 2010

PD-L1 (B7-H1) and PD-1 Pathway Blockade for Cancer Therapy: Mechanisms, Response Biomarkers and Combinations

Por Zou, Weiping, Wolchok, Jedd D., Chen, Lieping
Publicado no Sci Transl Med (2016)

Beyond Cancer Vaccines: A Reason for Future Optimism with Immunomodulatory Therapy

Por Postow, Michael, Callahan, Margaret K., Wolchok, Jedd D.
Publicado em 2011

Modulation of GITR for cancer immunotherapy

Por Schaer, David A, Murphy, Judith T, Wolchok, Jedd D
Publicado em 2012

Myeloid-derived suppressor cells and the efficacy of CD8(+) T-cell immunotherapy

Por Lesokhin, Alexander M., Merghoub, Taha, Wolchok, Jedd D.
Publicado em 2013

Targeting Immune Checkpoints: Releasing the Restraints on Anti-tumor Immunity for Patients with Melanoma

Por Postow, Michael A., Harding, James, Wolchok, Jedd D.
Publicado em 2012

Anti-CTLA-4 Antibody Therapy: Immune Monitoring During Clinical Development of a Novel Immunotherapy

Por Callahan, Margaret K., Wolchok, Jedd D., Allison, James P.
Publicado em 2010

Hiding the road signs that lead to tumor immunity

Por Schaer, David A., Lesokhin, Alexander M., Wolchok, Jedd D.
Publicado em 2011

Monoclonal antibodies in cancer therapy

Por Scott, Andrew M., Allison, James P., Wolchok, Jedd D.
Publicado em 2012

Immunomodulatory Therapy for Melanoma: Ipilimumab and Beyond

Por Callahan, Margaret K., Postow, Michael A., Wolchok, Jedd D.
Publicado em 2013

Targeting tumor-necrosis factor receptor pathways for tumor immunotherapy

Por Schaer, David A, Hirschhorn-Cymerman, Daniel, Wolchok, Jedd D
Publicado em 2014

CTLA-4 and PD-1 Pathway Blockade: Combinations in the Clinic

Por Callahan, Margaret K., Postow, Michael A., Wolchok, Jedd D.
Publicado no Front Oncol (2015)